Literature DB >> 2299491

Modulation of abnormal defecation dynamics by biofeedback treatment in chronically constipated children with encopresis.

V Loening-Baucke1.   

Abstract

To determine whether outcome in chronically constipated and encopretic children with abnormal defecation dynamics could be improved with biofeedback training, we randomly assigned patients, 5 to 16 years of age, to receive conventional treatment alone (n = 19) or conventional plus biofeedback treatment (n = 22) and evaluated physiologic outcome at 7 months and clinical outcome at 7 and 12 months. Eighty-six percent of patients learned normal defecation dynamics with up to six biofeedback sessions. At 7 months, 13% of conventionally treated and 77% of biofeedback-treated patients had normal defecation dynamics (p less than 0.01); one conventionally treated (5%) and 12 biofeedback-treated patients (55%) had recovered (p less than 0.01). Learning normal defecation dynamics was correlated with clinical recovery (p less than 0.01). At 7 months, 11% of patients with normal defecation dynamics after biofeedback treatment had abnormal defecation dynamics, and 71% of the biofeedback-treated patients with normal defecation dynamics recovered. At 12 months, 16% of conventionally treated and 50% of biofeedback-treated patients had recovered (p less than 0.05). Balloon defecation did not improve significantly in those who learned normal defecation dynamics. Therefore the ability to defecate balloons is apparently not dependent on the normal function of the external and sphincter and pelvic floor muscles alone. Biofeedback treatment is complementary to a good conventional therapeutic regimen in patients with abnormal defecation dynamics.

Entities:  

Mesh:

Year:  1990        PMID: 2299491     DOI: 10.1016/s0022-3476(05)82877-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  30 in total

Review 1.  Behavioural and cognitive interventions with or without other treatments for the management of faecal incontinence in children.

Authors:  Miriam Brazzelli; Peter V Griffiths; June D Cody; David Tappin
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Biofeedback for pelvic floor dysfunction in constipation.

Authors:  G Bassotti; F Chistolini; F Sietchiping-Nzepa; G de Roberto; A Morelli; G Chiarioni
Journal:  BMJ       Date:  2004-02-14

3.  Subtypes of constipation predominant irritable bowel syndrome based on rectal perception.

Authors:  F Harraf; M Schmulson; L Saba; N Niazi; R Fass; J Munakata; D Diehl; H Mertz; B Naliboff; E A Mayer
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

4.  Constipation in Childhood: How early recognition can prevent serious problems.

Authors:  V J Ebelt; D Riddell
Journal:  Can Fam Physician       Date:  1992-09       Impact factor: 3.275

5.  Constipation and biofeedback in children.

Authors:  A Wald
Journal:  Dig Dis Sci       Date:  1996-08       Impact factor: 3.199

Review 6.  Childhood constipation as an emerging public health problem.

Authors:  Shaman Rajindrajith; Niranga Manjuri Devanarayana; Bonaventure Jayasiri Crispus Perera; Marc Alexander Benninga
Journal:  World J Gastroenterol       Date:  2016-08-14       Impact factor: 5.742

7.  Diagnostic dilemmas and results of treatment for chronic constipation.

Authors:  C W Keuzenkamp-Jansen; C J Fijnvandraat; C M Kneepkens; A C Douwes
Journal:  Arch Dis Child       Date:  1996-07       Impact factor: 3.791

8.  Randomised controlled trial of biofeedback training in persistent encopresis with anismus.

Authors:  T Nolan; T Catto-Smith; C Coffey; J Wells
Journal:  Arch Dis Child       Date:  1998-08       Impact factor: 3.791

9.  Effects of biofeedback on obstructive defecation--reconditioning of the defecation reflex?

Authors:  M Papachrysostomou; A N Smith
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

10.  Psychosocial co-morbidity affects treatment outcome in children with fecal incontinence.

Authors:  Els Q van Everdingen-Faasen; Bert J Gerritsen; Paul G H Mulder; Ellen A Fliers; Michael Groeneweg
Journal:  Eur J Pediatr       Date:  2007-10-19       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.